Biotrin raises $5.5 million:
This article was originally published in Clinica
Executive Summary
Irish biotech company Biotrin has raised IR£3.5 million ($5.5 million) in a second round of financing. The funds will be used to obtain US product approvals and to develop home tests for transplantation patients and a rapid assay for organ selection.